Siegfried soars on 'massive' H1 beat
18/08/2022 08:53
** Shares in Siegfried Holding SFZN.S jump 11.2% after the
Swiss pharmaceutical company beat its first-half expectations
** The company reports H1 net income doubling to CHF 65.2
million ($68.4 million) urn:newsml:reuters.com:*:nL8N2ZU1GU
** Siegfried raised its 2022 outlook to sales growth of more
than 15% from its previous high-single to low-double-digit
percentage range
** "Massive consensus beat with H1 reporting," Baader Helvea
says, adding that the earnings beat was beyond the broker's most
bullish estimates
** It says H1 sales, EBITDA, and net income were 8%, 18% and
33% ahead of consensus, respectively
** Vontobel says Siegfried has gained momentum, the business
looks much better, and trends are good
** The stock tops the STOXX 600 index .STOXX
($1 = 0.9535 Swiss francs)
(Reporting by Bartosz Dabrowski in Gdansk)
((bartosz.dabrowski@thomsonreuters.com; +48 58 7696560;))